Patient resource

When depression doesn't respond: what comes next

By Josephine W. Hazeley, MSN, PMHNP-BC
Board-certified psychiatric mental health nurse practitioner with a perinatal & postpartum focus — nearly two decades in psychiatric nursing, including research nursing on the trial behind the first FDA-approved postpartum-depression therapy. About your clinician

Clinically reviewed by Josephine W. Hazeley, PMHNP-BC on · Last updated

When two or more adequate antidepressant trials haven’t produced enough improvement, clinicians call it treatment-resistant depression — and it is a well-mapped situation, not a dead end. The next moves include optimizing or switching medications, augmenting with a second one, adding therapy, and, further along, brain-stimulation options for depression that hasn’t responded to psychotherapy and medication (NIMH). This is general education about the map, not advice about your specific medication, which only your prescriber can give.

If the first antidepressant fell short, start with what happens when the first antidepressant doesn’t work. This piece picks up further down the road, as part of depression treatment in North Carolina, when several steps have already been tried.

What does “treatment-resistant” actually mean?

That depression hasn’t improved enough after adequate trials, not that it is untreatable. The term generally refers to an inadequate response after two or more antidepressants taken at an adequate dose for an adequate length of time. Two words in that definition carry weight: adequate dose and adequate length. A medication stopped too early or kept too low was never a fair test, so the first question is often whether the earlier trials were complete ones.

The label sounds discouraging, but the evidence behind it is the opposite. It exists precisely because there is a structured sequence of next steps to work through.

What did STAR*D show about later steps?

That persistence pays, even if the odds shift. In STAR*D, the largest real-world depression trial, remission rates were lower at each later treatment step than at the first — and yet people who did not remit early still reached remission later, adding to the cumulative total. The takeaway is not that late steps are hopeless; it is that a stepwise approach keeps producing recoveries that a single trial would have missed.

What are the medication and therapy options?

The established directions after an inadequate response are laid out in the APA Practice Guideline for Major Depressive Disorder:

  • Optimize the current medication — confirm the dose and duration were adequate before abandoning it.
  • Switch to a different antidepressant, in the same class or one that works differently, when there was little benefit or an intolerable side effect.
  • Augment by adding a second medication to build on a partial response rather than replacing the first.
  • Combine medication with psychotherapy, on its own or alongside a medication change.

Which direction fits depends on how you responded — no response, partial response, or a tolerability problem — plus your history and preferences. Measurement-based care, tracking your symptoms with a brief questionnaire at each visit, is what tells a prescriber which of these the evidence supports for you.

What about brain-stimulation treatments?

They exist for the depression that hasn’t responded to the steps above. Brain-stimulation therapies are options for depression that has not improved with psychotherapy and medication (NIMH). Most people never need them, and they sit further along the map than the medication and therapy adjustments most treatment works through. Knowing the map extends past two stops matters, though — it is the reason “nothing has worked yet” is not the same as “nothing will.”

How MCW approaches this

A follow-up visit for depression that hasn’t responded reviews what has been tried, at what dose and for how long, what you felt and didn’t, side effects, and a current symptom score, then works out whether optimizing, switching, augmenting, or adding therapy fits. Where a case calls for care beyond what telehealth medication management provides, a clinician says so and helps point toward the right level of care rather than repeating a step that isn’t working.

What’s the next step?

If depression has held on through more than one treatment, an evaluation to review the full history is the productive next move. It can be done by telehealth anywhere in North Carolina. Request an appointment through Get Started or call (919) 739-3808. New patients are typically seen within 1–3 business days.

If you or someone you know is in crisis, call or text 988 (Suicide & Crisis Lifeline) or call 911.

Sources